artenimol has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lacoste, E; Lai, H; Nakase, I; Sasaki, T; Singh, NP | 1 |
| Hassan, ZM; Noori, S | 1 |
2 other study(ies) available for artenimol and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Artemisinin-transferrin conjugate retards growth of breast tumors in the rat.
Topics: Adenocarcinoma; Animals; Artemisinins; Female; Injections, Intravenous; Mammary Neoplasms, Experimental; Random Allocation; Rats; Rats, Inbred F344; Transferrin | 2009 |
Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo.
Topics: Animals; Antimalarials; Artemisinins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Female; Hindlimb; Hypersensitivity, Delayed; Inhibitory Concentration 50; Injections, Intraperitoneal; Interferon-gamma; Interleukin-4; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Sheep; T-Lymphocytes; T-Lymphocytes, Regulatory; Th1 Cells; Tumor Burden | 2011 |